Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Hedberg

Showing results (71-80 of 85) with videos related to

Pageof 9
Sort By:
Lupus|May 13, 2009
Circulating chromatin-anti-chromatin antibody complexes bind with high affinity to dermo-epidermal structures in murine and human lupus nephritisS Fismen, A Hedberg, K A Fenton, et al.
Journal of Medicinal Chemistry|May 1, 1990
Dihydropyrimidine calcium channel blockers: 2-heterosubstituted 4-aryl-1,4-dihydro-6-methyl-5-pyrimidinecarboxylic acid esters as potent mimics of dihydropyridinesK S Atwal, G C Rovnyak, J Schwartz, et al.
Bioorganic & Medicinal Chemistry|October 1, 1993
Conformationally constrained calcium channel blockers: novel mimics of 1-benzazepin-2-onesJ C Barrish, S H Spergel, S Moreland, et al.
The Journal of Antibiotics|November 1, 1987
Identification of macrotetrolide antibiotics in a screen to detect calcium channel blocking agentsJ E Biskupiak, J H Johnson, M Forte, et al.
Journal of Medicinal Chemistry|August 21, 1992
Dihydropyrimidine calcium channel blockers. 4. Basic 3-substituted-4-aryl-1,4-dihydropyrimidine-5-carboxylic acid esters. Potent antihypertensive agentsG C Rovnyak, K S Atwal, A Hedberg, et al.
Journal of Medicinal Chemistry|January 6, 1995
Calcium entry blockers and activators: conformational and structural determinants of dihydropyrimidine calcium channel modulatorsG C Rovnyak, S D Kimball, B Beyer, et al.
Peptides|May 1, 1992
Molecular characterization of angiotensin II type II receptors in rat pheochromocytoma cellsM L Webb, E C Liu, R B Cohen, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 1, 1991
Structurally novel antihypertensive compound, McN-5691, is a calcium channel blocker in vascular smooth muscleS F Flaim, M M Gleason, A Hedberg, et al.
Bioorganic & Medicinal Chemistry|July 1, 1993
Structure-activity studies of endothelin leading to novel peptide ETA antagonistsJ T Hunt, V G Lee, D McMullen, et al.
Journal of Medicinal Chemistry|June 1, 1990
9,11-epoxy-9-homoprosta-5-enoic acid analogues as thromboxane A2 receptor antagonistsJ Das, S E Hall, M Nakane, et al.
Pageof 9

Showing results (71-80 of 85) with videos related to

Sort By:
Pageof 9
Lupus|May 13, 2009
Circulating chromatin-anti-chromatin antibody complexes bind with high affinity to dermo-epidermal structures in murine and human lupus nephritisS Fismen, A Hedberg, K A Fenton, et al.
Journal of Medicinal Chemistry|May 1, 1990
Dihydropyrimidine calcium channel blockers: 2-heterosubstituted 4-aryl-1,4-dihydro-6-methyl-5-pyrimidinecarboxylic acid esters as potent mimics of dihydropyridinesK S Atwal, G C Rovnyak, J Schwartz, et al.
Bioorganic & Medicinal Chemistry|October 1, 1993
Conformationally constrained calcium channel blockers: novel mimics of 1-benzazepin-2-onesJ C Barrish, S H Spergel, S Moreland, et al.
The Journal of Antibiotics|November 1, 1987
Identification of macrotetrolide antibiotics in a screen to detect calcium channel blocking agentsJ E Biskupiak, J H Johnson, M Forte, et al.
Journal of Medicinal Chemistry|August 21, 1992
Dihydropyrimidine calcium channel blockers. 4. Basic 3-substituted-4-aryl-1,4-dihydropyrimidine-5-carboxylic acid esters. Potent antihypertensive agentsG C Rovnyak, K S Atwal, A Hedberg, et al.
Journal of Medicinal Chemistry|January 6, 1995
Calcium entry blockers and activators: conformational and structural determinants of dihydropyrimidine calcium channel modulatorsG C Rovnyak, S D Kimball, B Beyer, et al.
Peptides|May 1, 1992
Molecular characterization of angiotensin II type II receptors in rat pheochromocytoma cellsM L Webb, E C Liu, R B Cohen, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 1, 1991
Structurally novel antihypertensive compound, McN-5691, is a calcium channel blocker in vascular smooth muscleS F Flaim, M M Gleason, A Hedberg, et al.
Bioorganic & Medicinal Chemistry|July 1, 1993
Structure-activity studies of endothelin leading to novel peptide ETA antagonistsJ T Hunt, V G Lee, D McMullen, et al.
Journal of Medicinal Chemistry|June 1, 1990
9,11-epoxy-9-homoprosta-5-enoic acid analogues as thromboxane A2 receptor antagonistsJ Das, S E Hall, M Nakane, et al.
Pageof 9